Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024135496> ?p ?o ?g. }
- W2024135496 endingPage "309" @default.
- W2024135496 startingPage "303" @default.
- W2024135496 abstract "Since sorafenib, a multikinase inhibitor targeting angiogenesis of hepatocellular carcinoma (HCC), demonstrated survival benefits in recent clinical trials, it has changed the treatment paradigm and become the standard first-line treatment for patients with advanced HCC. However, disease stabilization with sorafenib lasts a few months, possibly due to the development of resistance, and thus the survival advantage was modest, even in patients with preserved liver function. Furthermore, there is currently no biomarker for monitoring the response or resistance to sorafenib. Currently, various kinds of molecularly targeted agents have been developed and are being evaluated in clinical trials. There are several steps required to improve the outcome from sorafenib therapy. First, a reliable predictive and prognostic biomarker is urgently needed. Second, a compelling indication of sorafenib treatment for HCC needs more clinical studies and consensus. Third, the actual benefits of sorafenib to patients with advanced liver dysfunction should be clarified and a more effective strategy for targeted therapy needs to be developed, for example, using a combination of targeted agents acting on different pathways or different levels of a key pathway. Finally, sorafenib could be used with other treatment modalities, such as local ablation or transarterial chemoembolization, to synergize efficacy. Based on the successful introduction of sorafenib, future studies should focus on plans to further improve the outcome of HCC patients by overcoming resistance and maximizing the efficacy of molecularly targeted therapy." @default.
- W2024135496 created "2016-06-24" @default.
- W2024135496 creator A5011174725 @default.
- W2024135496 creator A5060317969 @default.
- W2024135496 date "2011-01-01" @default.
- W2024135496 modified "2023-09-27" @default.
- W2024135496 title "Molecularly Targeted Therapies for Hepatocellular Carcinoma: Sorafenib as a Stepping Stone" @default.
- W2024135496 cites W1587274334 @default.
- W2024135496 cites W1967600348 @default.
- W2024135496 cites W1971837077 @default.
- W2024135496 cites W1973852736 @default.
- W2024135496 cites W1977999028 @default.
- W2024135496 cites W1986209953 @default.
- W2024135496 cites W1988148746 @default.
- W2024135496 cites W1994193851 @default.
- W2024135496 cites W1994762365 @default.
- W2024135496 cites W1996703005 @default.
- W2024135496 cites W1997533142 @default.
- W2024135496 cites W1998015154 @default.
- W2024135496 cites W2000793790 @default.
- W2024135496 cites W2003278673 @default.
- W2024135496 cites W2012582581 @default.
- W2024135496 cites W2016364458 @default.
- W2024135496 cites W2016569548 @default.
- W2024135496 cites W2022169488 @default.
- W2024135496 cites W2040675540 @default.
- W2024135496 cites W2043103956 @default.
- W2024135496 cites W2046237862 @default.
- W2024135496 cites W2050637252 @default.
- W2024135496 cites W2053526872 @default.
- W2024135496 cites W2060439279 @default.
- W2024135496 cites W2081557581 @default.
- W2024135496 cites W2084952307 @default.
- W2024135496 cites W2114029473 @default.
- W2024135496 cites W2115497785 @default.
- W2024135496 cites W2125763116 @default.
- W2024135496 cites W2136977965 @default.
- W2024135496 cites W2140088548 @default.
- W2024135496 cites W2141274529 @default.
- W2024135496 cites W2145803146 @default.
- W2024135496 cites W2153935627 @default.
- W2024135496 cites W2155152791 @default.
- W2024135496 cites W2156012497 @default.
- W2024135496 cites W2156871508 @default.
- W2024135496 cites W2157535532 @default.
- W2024135496 cites W2162242700 @default.
- W2024135496 cites W2163486683 @default.
- W2024135496 cites W2166805191 @default.
- W2024135496 cites W2168041959 @default.
- W2024135496 cites W23438228 @default.
- W2024135496 cites W2406052883 @default.
- W2024135496 cites W2510225419 @default.
- W2024135496 doi "https://doi.org/10.1159/000327563" @default.
- W2024135496 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21829021" @default.
- W2024135496 hasPublicationYear "2011" @default.
- W2024135496 type Work @default.
- W2024135496 sameAs 2024135496 @default.
- W2024135496 citedByCount "22" @default.
- W2024135496 countsByYear W20241354962012 @default.
- W2024135496 countsByYear W20241354962013 @default.
- W2024135496 countsByYear W20241354962014 @default.
- W2024135496 countsByYear W20241354962015 @default.
- W2024135496 countsByYear W20241354962016 @default.
- W2024135496 countsByYear W20241354962017 @default.
- W2024135496 countsByYear W20241354962018 @default.
- W2024135496 countsByYear W20241354962020 @default.
- W2024135496 countsByYear W20241354962021 @default.
- W2024135496 countsByYear W20241354962022 @default.
- W2024135496 countsByYear W20241354962023 @default.
- W2024135496 crossrefType "journal-article" @default.
- W2024135496 hasAuthorship W2024135496A5011174725 @default.
- W2024135496 hasAuthorship W2024135496A5060317969 @default.
- W2024135496 hasConcept C121608353 @default.
- W2024135496 hasConcept C126322002 @default.
- W2024135496 hasConcept C143998085 @default.
- W2024135496 hasConcept C185592680 @default.
- W2024135496 hasConcept C2776248978 @default.
- W2024135496 hasConcept C2776999253 @default.
- W2024135496 hasConcept C2778019345 @default.
- W2024135496 hasConcept C2778695046 @default.
- W2024135496 hasConcept C2781197716 @default.
- W2024135496 hasConcept C2781230642 @default.
- W2024135496 hasConcept C526805850 @default.
- W2024135496 hasConcept C535046627 @default.
- W2024135496 hasConcept C55493867 @default.
- W2024135496 hasConcept C71924100 @default.
- W2024135496 hasConceptScore W2024135496C121608353 @default.
- W2024135496 hasConceptScore W2024135496C126322002 @default.
- W2024135496 hasConceptScore W2024135496C143998085 @default.
- W2024135496 hasConceptScore W2024135496C185592680 @default.
- W2024135496 hasConceptScore W2024135496C2776248978 @default.
- W2024135496 hasConceptScore W2024135496C2776999253 @default.
- W2024135496 hasConceptScore W2024135496C2778019345 @default.
- W2024135496 hasConceptScore W2024135496C2778695046 @default.
- W2024135496 hasConceptScore W2024135496C2781197716 @default.
- W2024135496 hasConceptScore W2024135496C2781230642 @default.
- W2024135496 hasConceptScore W2024135496C526805850 @default.
- W2024135496 hasConceptScore W2024135496C535046627 @default.